Society for Neuroscience (SfN) 2022 | November 12-16

Fosgonimeton, a Small-Molecule Positive Modulator of HGF/MET, Protects Against Neuronal Damage and Motor Deficits in Preclinical Models of Parkinson’s Disease

Small-Molecule Hepatocyte Growth Factor/MET Positive Modulators Effectively Reduce Pain-Related Behaviors in a Rat Model of Diabetic Neuropathy